apalutamide Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Male only (2)
Any (1)

Phase 0 (1)
Phase 1 (1)
Phase 3 (1)

Interventional (2)

Celgene (1)
Chinese University of Hong Kong (1)

No (3)

No (3)

Adult (18+) (3)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadprostate cancer

I am/have/hadadenocarcinoma of prostate

I am/have/hadandrogen deprivation

I am/have/hadadenocarcinoma

I am/have/hadprostatectomy

I am/have/hadmetastatic castration-resistant prostate cancer

I am/have/hadcastration-resistant prostate cancer

I am/have/hadserum testosterone

I am/have/hadrecurrent prostate cancer

I am/have/hadgonadotropin

I am/have/hadbilateral orchidectomy

I am/have/hadmetastatic hormone refractory prostate cancer

I am/have/hadluteinizing hormone

I am/have/hadorchiectomy

I am/have/hadandrogen suppression

added new label for I am/have/had

I am looking for

I am looking forapalutamide

I am looking forantiandrogen therapy

I am looking fortestosterone

I am looking forgonadotropin releasing hormone

I am looking forhormone therapy

I am looking forgonadotropin

I am looking forabiraterone

I am looking forandrogens

I am looking forenzalutamide

I am looking fordarolutamide

I am looking forluteinizing hormone

I am looking forgonadorelin

I am looking forendocrine therapy

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Males
Family Medicine
Recruiting

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

This is a prospective, open-label, randomized, controlled, cross-over trial assessing patient preference for apalutamide versus enzalutamide in 146 male patients with recurrent or metastatic hormone-sensitive prostate cancer. The primary objective is to investigate whether there is any difference in patient preference between apalutamide and enzalutamide in patients with recurrent or …

cancer

androgens

androgen deprivation

prostatectomy

antiandrogen therapy

0 views
16 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Males
Family Medicine
Recruiting

Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

abiraterone

androgens

bilateral orchidectomy

metastatic hormone refractory prostate cancer

prostate cancer

0 views
05 Aug, 2020

Phase 1
all
Recruiting

Test Trial 002

test comment here

0 views
05 Apr, 2023
1 location